Pramodini Medicare Ltd.
SMENSE₹110–118
₹ 53 Cr
2400 Shares
₹ 2,64,000
₹10
Financial Summary
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| 6,228.75 | 3,823.77 | |
| 109.09 | 30.86 | |
| 6,337.84 | 3,854.63 | |
| 3,138.39 | 1,727.16 | |
| 2,330.12 | 1,575.11 | |
| 1,737.73 | 1,113.99 |
Subscription Details
IPO Timeline
IPO Offer Start
12 Aug 2026
IPO Offer Ends
14 Aug 2026
19 Aug 2026
Use of Proceeds
| # | Purpose | Amount (₹ Million) |
|---|---|---|
| 1 | Funding of capital expenditure for purchase of Medical Equipments | 451.485 |
| 2 | General corporate purposes and unidentified inorganic acquisition | 107.575 |
Promoters
Book Running Lead Managers
Promoter Shareholding
Pre-IPO
85.71%
Promoter stake
Post-IPO
62.64%
Promoter stake
Offered to Public
44,90,400
shares
Post Share Capital
1,38,09,077
shares
About the Company
We are a diagnostic service provider in India. We provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Our diagnostic services include a comprehensive range of offerings: (i) “Radiology” which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, Dexa Scan and Intervention Radiology, (ii) “Clinical Laboratory” which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) “Nuclear Medicine” which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy. We also provide teleradiology services through our registered office situated at Vijayawada which functions on a 24×7 basis throughout the year. We provide healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Our services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
Use of Proceeds
1. Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres; and 2. General corporate purposes and unidentified inorganic acquisition.
Pramodini Medicare Ltd. Latest News
IPO FAQs
The Pramodini Medicare Ltd. IPO has a total of ₹53 crore, calculated at the upper end of the .
The Pramodini Medicare Ltd. IPO is priced at ₹110–118 per share. bids must fall within this , against a of ₹10 per share.
The for the Pramodini Medicare Ltd. IPO is 2,400 shares, which is also the minimum order quantity — you have to apply for at least 2,400 shares, and in multiples of 2,400 beyond that.
The minimum investment in the Pramodini Medicare Ltd. IPO is about ₹2,64,000 — one lot of 2,400 shares, calculated at the lower end of the .
Bidding at the cut-off or upper price raises the amount blocked in your account.
The Pramodini Medicare Ltd. opens on 12 Aug 2026 and closes on 14 Aug 2026.
Applications have to be in before 5:00 PM IST on the closing day, and your UPI mandate needs to be approved by then as well.
Pramodini Medicare Ltd. shares were listed on 19 Aug 2026 on NSE.
Purva Shareregistry (India) Pvt Ltd is the for the Pramodini Medicare Ltd. IPO.
The registrar processes the , refunds and the credit of shares to your demat account, so allotment-status queries go to them — email busicomp@vsnl.com.
Pramodini Medicare Ltd. IPO shares are listed on NSE.
Each Pramodini Medicare Ltd. share has a of ₹10.
Face value is the nominal value recorded in the company's books and is separate from the issue price you pay.
held 85.71% of Pramodini Medicare Ltd. before the IPO, which falls to 62.64% after the issue.
44,90,400 shares of Pramodini Medicare Ltd. are being offered to the public in this issue.
- 1.Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres
- 2.General corporate purposes and unidentified inorganic acquisition
Smart Horizon Capital Advisors Pvt Ltd. is the book running lead manager for the Pramodini Medicare Ltd. IPO.
Pre-apply means placing your Pramodini Medicare Ltd. application before the subscription window actually opens. The bid is held and forwarded to the exchange on the opening day, so you don't have to submit it in the rush of the first morning.
Applying early doesn't improve your chances — when an issue is oversubscribed, the for investors is decided by a lottery, not by who applied first. Your money is only blocked once the application reaches the exchange.
You can apply in the Pramodini Medicare Ltd. IPO online using either UPI or ASBA as the payment method. ASBA applications are made through the net banking of a bank account that supports IPO applications — the bank blocks the amount in your account instead of debiting it. UPI applications are offered by brokers that don't provide banking services: you enter your UPI ID and then approve the mandate request in your UPI app.
Either route needs a demat account. You bid for at least one lot, at a price within the or at the cut-off price, and the money stays blocked in your bank account until the is finalised.
Your broker or bank confirms the bid once it has been submitted to the exchange, usually within a few minutes during the bidding window. A UPI application only goes live after you approve the mandate request — ignore it and the bid lapses, even though it looks placed.
You can check the Pramodini Medicare Ltd. bid independently on the NSE or BSE IPO bid-verification page a day after applying. An ASBA application also shows up as a blocked amount in your bank statement.